Ph II CABOGIST in GIST

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

February 2, 2017

Primary Completion Date

May 20, 2019

Study Completion Date

February 23, 2021

Conditions
Metastatic Gastrointestinal Stromal Tumor
Interventions
DRUG

cabozantinib

Oral

Trial Locations (11)

Unknown

U.Z. Leuven - Campus Gasthuisberg (147), Leuven

University Hospital Motol (1905), Prague

Institut Bergonie (228), Bordeaux

Centre Leon Berard (227), Lyon

Gustave Roussy (225), Villejuif

UniversitaetsMedizin Mannheim (527), Mannheim

Military Hospital - State Health Centre (3769), Budapest

Clatterbridge Centre for Oncology NHS Trust - Clatterbridge Cancer Centre NHS Foundation Trust (659), Bebington

Royal Marsden Hospital - Chelsea, London (613), Chelsea

University College London Hospitals NHS Foundation Trust - University College Hospital (622), London

The Christie NHS Foundation Trust (610), Manchester

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT02216578 - Ph II CABOGIST in GIST | Biotech Hunter | Biotech Hunter